Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07BQN
|
|||
| Former ID |
DNC009862
|
|||
| Drug Name |
N-(3,3-Diphenyl-propyl)-2-pyridine-3-ylacetamide
|
|||
| Synonyms |
CHEMBL563527; N-(3,3-Diphenyl-propyl)-2-pyridine-3-ylacetamide; SCHEMBL4619635
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H22N2O
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C(CCNC(=O)CC2=CN=CC=C2)C3=CC=CC=C3
|
|||
| InChI |
1S/C22H22N2O/c25-22(16-18-8-7-14-23-17-18)24-15-13-21(19-9-3-1-4-10-19)20-11-5-2-6-12-20/h1-12,14,17,21H,13,15-16H2,(H,24,25)
|
|||
| InChIKey |
FNEXDTNOFQXKRJ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Soluble epoxide hydrolase (EPHX2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Peroxisome | ||||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Metapathway biotransformation | |||
| Arachidonate Epoxygenase / Epoxide Hydrolase | ||||
| Arachidonic acid metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase. J Med Chem. 2009 Oct 8;52(19):5880-95. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.